NOVEL FOLR1 SPECIFIC BINDING PROTEINS FOR CANCER DIAGNOSIS AND TREATMENT
Application
US20260078155A1
Kind: A1
Mar 19, 2026
Inventors
Erik Fiedler, Ulrich Haupts, Manja Gloser-Bräunig, Eva Bosse-Doenecke
Abstract
The present invention relates to new binding proteins that are specific for folate receptor alpha (FOLR1). The invention further refers to FOLR1 binding proteins that further comprises a diagnostically or therapeutically active component. Further aspects of the invention cover the use of these FOLR1 binding proteins in medicine, for example, in diagnosis and therapy of FOLR1 related cancer.
CPC Classifications
C07K 14/4702
A61K 47/64
A61K 38/00
Filing Date
2025-11-26
Application No.
19402970